Leptin in humans: lessons from translational research
Open Access
- 1 March 2009
- journal article
- review article
- Published by Elsevier BV in The American Journal of Clinical Nutrition
- Vol. 89 (3), 991S-997S
- https://doi.org/10.3945/ajcn.2008.26788e
Abstract
Leptin has emerged over the past decade as a key hormone in not only the regulation of food intake and energy expenditure but also in the regulation of neuroendocrine and immune function as well as the modulation of glucose and fat metabolism as shown by numerous observational and interventional studies in humans with (complete) congenital or relative leptin deficiency. These results have led to proof-of-concept studies that have investigated the effect of leptin administration in subjects with complete (congenital) leptin deficiency caused by mutations in the leptin gene as well as in humans with relative leptin deficiency, including states of lipoatrophy or negative energy balance and neuroendocrine dysfunction, as for instance seen with hypothalamic amenorrhea in states of exercise-induced weight loss. In those conditions, most neuroendocrine, metabolic, or immune disturbances can be restored by leptin administration. Leptin replacement therapy is thus a promising approach in several disease states, including congenital complete leptin deficiency, states of energy deprivation, including anorexia nervosa or milder forms of hypothalamic amenorrhea, as well as syndromes of insulin resistance seen in conditions such as congenital or acquired lipodystrophy. In contrast, states of energy excess such as garden-variety obesity are associated with hyperleptinemia that reflects either leptin tolerance or leptin resistance. For those conditions, development of leptin sensitizers is currently a focus of pharmaceutical research. This article summarizes our current understanding of leptin’s role in human physiology and its potential role as a novel therapeutic option in human disease states associated with a new hormone deficiency, ie, leptin deficiency.Keywords
This publication has 41 references indexed in Scilit:
- From observation to experimentation: leptin action in the mediobasal hypothalamusThe American Journal of Clinical Nutrition, 2009
- Leptin at 14 y of age: an ongoing storyThe American Journal of Clinical Nutrition, 2009
- Leptin Does Not Mediate Short-Term Fasting-Induced Changes in Growth Hormone Pulsatility but Increases IGF-I in Leptin Deficiency StatesJournal of Clinical Endocrinology & Metabolism, 2008
- Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studiesProceedings of the National Academy of Sciences, 2008
- Adipocytes and adipose tissueBest Practice & Research Clinical Endocrinology & Metabolism, 2008
- Clinical and Molecular Genetic Spectrum of Congenital Deficiency of the Leptin ReceptorNew England Journal of Medicine, 2007
- Anterior Pituitary Leptin Expression Changes in Different Reproductive States: In Vitro Stimulation by Gonadotropin-releasing HormoneJournal of Histochemistry & Cytochemistry, 2006
- Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humansProceedings of the National Academy of Sciences, 2006
- Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiencyJCI Insight, 2002
- Leptin-Replacement Therapy for LipodystrophyNew England Journal of Medicine, 2002